Depression, anxiety, and obesityobesitycanada.ca/wp-content/uploads/2018/08/5AsT... · 2018. 8....

Post on 02-Mar-2021

2 views 0 download

Transcript of Depression, anxiety, and obesityobesitycanada.ca/wp-content/uploads/2018/08/5AsT... · 2018. 8....

Depression, anxiety, and obesity 5As Team Learning modules

Depression and anxiety are two prevalent mood disorders that affect Canadians, withas many as 40-70% of overweight/obese individuals at high risk of depression. When consulting and treating patients with obesity, it is important to take a holistic approach using a biological, psychological and social evaluation of their health. Obesity is a chronic condition that encompasses a variety of causes and complications, and mental illness is unique in that it has potential to be both a cause and a complication. As a primary care health practitioner, it is important to learn to recognize your patients’ risk factors for depression and anxiety disorders. Understanding how these conditions are linked to obesity will go a long way when tailoring your treatment and management plan for each individual patient.

Dr. Brian Stonehocker is an assistant clinical professor and residency program director in the University of Alberta Department of Psychiatry. As a practicing psychiatrist and consultant to the Alberta Health Services’ Weight Wise program, Dr. Stonehocker has worked on several projects looking at the relationship between mental health and obesity. His primary area of expertise is in consultation liaison psychiatry, the branch of psychiatry that specializes in the interface between medicine and psychiatry.

This module contains:

• A link to the video on depression, anxiety, and obesity

o https://www.youtube.com/watch?v=-2KLrJAssMM

• A PowerPoint presentation (page 2-32) that covers the following topics:

o The aetiology and determinants of obesityo Medical complications of obesityo Mental health as a cause of obesity and barrier to effective managemento Obesity as a risk factor for depression and anxiety disorders

The role of antidepressant therapy in weight gain

• A discussion guide for further reflection (page 33)

Mood and Food

Dr. Brian Stonehocker

University of Alberta

Department of Psychiatry

Alberta Health Services Weight Wise 2

www.obesitynetwork.ca 3

%

1E

34

42

2

30*

4* 5

17

44*

3* 6

14

0

5

10

15

20

25

30

35

40

45

50

Under- weight

Normal weight

Overweight (not obese)

Obese Class I

Obese Class II

Obese Class III

Men Women

Weight Distribution in the Canadian Population

Data from: Statistics Canada. 4

Medical Complications of Obesity

Idiopathic Intracranial Hypertension

Stroke

Cataracts

Accelerated Atherosclerosis Coronary Heart Disease Diabetes

Dyslipidemia

Hypertension

Severe Pancreatitis

Cancer

Phlebitis venous stasis

breast, uterus, cervix, colon, esophagus, pancreas, kidney, prostate

Skin

Gout

Osteoarthritis

Pulmonary Disease

Nonalcoholic Fatty Liver Disease

Gall Bladder Disease

Gynecologic Abnormalities abnormal menses infertility polycystic ovarian syndrome

steatosis steatohypatitis cirrhosis

abnormal function obstructive sleep apnea hypoventilation syndrome

5

Edema = Positive Fluid Balance

Sharma & Padwal, Obes Rev 2009 6

Fluid In Fluid Out

X X

Sharma & Padwal, Obes Rev 2009 7

Energy In Energy Out

X X

Sharma & Padwal, Obes Rev 2009 8

HTN Diabetes Cardiovascular Disease

Osteoarthritis Sleep Apnea

9

Obesity

Obesity

10

Obesity

Obesity

11

Diabetes Cardiovascular Disease

HTN

12

Bariatric Surgery: Effect on Cardiovascular Risk

A Systematic Review and Meta-Analysis of 22,090 Patients

% r

esol

ved

62% 70%

77% 86%

Hypertension Dyslipidemia Diabetes Sleep Apnea

Buchwald H, et al. JAMA 2004;292:1724 13

Obesity

Obesity

14

Obesity

Obesities

15

An Aetiological Framework for Obesity

Metabolism Diet Activity

OUT IN

AGE

GENDER

GENETICS

HORMONES

SKELETAL MUSCLE

MEDICATIONS

SOCIO-CULTURAL

BIOMEDICAL

Homeostatic hyperphagia

MENTAL

Hedonic hyperphagia

MEDICATIONS

prednisone etc.

SOCIO-CULTURAL

BIOMEDICAL

Osteoarthritis, stroke etc.

MENTAL

Depression, social phobia

MEDICATIONS

beta-blockers etc. WEIGHT LOSS

Sharma A, Padwal R. Obesity Reviews, 2009 16

Mental Health as a Root Cause of Obesity

Altered Metabolism

• Medications

Increased Intake • Disordered Eating • ADHD • Mood and Anxiety • PTSD/Abuse • Medications

Reduced Activity • Depression • Medication 17

Mental Health as a Barrier to Obesity Management

• Reduced Capacity to Manage Change

– Concentration – Mood – Organizational Skills – Motivation – Energy

18

Mood Disorders: A Risk Factor for Metabolic Disturbance

• Diabetes mellitus and obesity are twice as prevalent in patients with mood disorders than control populations

• Insulin resistance leading to glucoregulatory disturbances may mediate cardiovascular, osteoporosis, cognitive abnormalities in mood disorders

• Bidirectional link between mood disorders and diabetes control

McIntyre RS, et al. Ann Clin Psychiatry. 2007 Oct-Dec;19(4):257-64 19

Depression in General Medical Conditions

HIV/AIDs 5 – 20%

Coronary Artery Disease 16 – 19%

Cerebrovascular Disease (stroke) 25 – 30%

Parkinson's Disease 28 – 51%

Epilepsy 20 – 55%

Various Cancers 5 – 20%

Diabetes Mellitus 20-40%

Overweight/Obesity 40-70%

20

Psychiatric Diagnoses in Patients Seeking Obesity Treatment

Kessler RC. Arch of Gen Psychiatry, 2005 21

In the link between food and mood – Psychiatric disorders like major depression and binge eating may contribute to the development of severe obesity in vulnerable individuals Some psychiatric disorders maybe a consequence of severe obesity in a culture that stigmatizes obesity.

Depression

• Many studies have documented a relationship between obesity and and increased risk of depression – Stronger association for women – Higher rates of depression in

people seeking obesity treatment than in the community

22

Does Obesity Lead to Depression?

• Several prospective studies have shown increased rates of depression when obese patients are followed over time

• Obesity at baseline increased the risk of onset of depression at follow-up

– OR 1.55; (95% CI 1.22-1.98)

Luppino, FS et. Al. Arch Gen Psychiatry 2010 Mar 23

Association stronger for Obesity than Overweight OR for Overweight was 1.27. Stronger for Americans than Europeans

Does treating Obesity cause Remission of

Depression? • Some patients may have improved

mood with weight loss – Fewer pain, physical symptoms

– Improved self esteem

• Pre-existing mood disorders often persist with weight loss

Jones-Corneille et al, Obesity Management, 2007 24

Evaluation of Depressed Mood

• Biological

• Psychological

• Social

25

Weight Gain with Antidepressants

26

Weight Gain

• Differential – Improvement in patients who lost

weight secondary to depression – Residual symptom (overeat when

depressed) – Side Effect

• Significant gain in acute phase • Gain continues despite remission

27

Weight Change During Maintenance Antidepressant

Treatment (>4 months) 6 5 4 3 2 1 0

-1 -2 -3

13.2 11.0 8.8 6.6 4.4 2.2 0 -2.2 -4.4 -6.6

Weight Change

(kg)

*

*

* *

Adapted from Serretti et al, J Clin Psych 71:10 2010.

*

* Filled squares indicate a significant effect.

Weight Change

(lb)

28

Weight Gain

• MAOI’s – Very common side effect

– Less likely with reversible MAOI’s (ie moclobemide)

• Tricyclics – Gain an average of 1.3 to 2.9 lbs per

month in first year

29

Weight Gain

• SSRI’s – Initially viewed as weight neutral or

associated with weight loss – Long term suggest an increase in

weight – Paroxetine more likely to cause

weight gain than Fluoxetine and Sertraline

30

Weight Gain

• SNRI’s –Venlafaxine

–Desvenlafaxine

–Duloxetine

• All relatively weight neutral

31

Weight Gain

• Mirtazipine (Remeron) – Antihistamine

– Significant weight gain

• Bupropion (Wellbutrin) – Slight weight loss overall

32

2

Discussion guide This is a guide for questions and topics to consider after viewing Dr. Stonehocker’s video and slide show on the topic of Depression, Anxiety, and Obesity. These questions may be discussed in a group or on your own.

1. Please take a moment on your own and consider what are the key messages you took from the speaker today (tips, messages, tools)?

o Of the information presented – how do you see yourself applying it in your practice?

o Were you surprised by the evidence suggesting a correlation between obesity and depression? Why or why not?

o What are some concerns that you have regarding the treatment options for patients with chronic mental illness? Are there any alternatives?

o How do these concerns change the way you approach patients seeking mental health support? And for patients seeking obesity treatment?

o What are some ways that we can proactively address mental health risks before they become a comorbid health problem?

o Is there anything you would like to learn more about on this topic?

2. Goal Setting o Take a few moments of quiet time to come up with your own goal concerning

a change you feel you can implement in your practice regarding mental health and obesity.

o Can you anticipate difficulties in achieving this goal? o Are you confident that you can reach your goal?